<DOC>
	<DOCNO>NCT01106339</DOCNO>
	<brief_summary>The purpose study define subgroup patient somatoform disorder due DSM-IV immunological , psychological genetic characterization .</brief_summary>
	<brief_title>Immune Patterns Pain Patients DSM-IV</brief_title>
	<detailed_description>Pain patient define patient somatoform disorder due DSM-IV , chronic pain last least 6 month several anatomical region . Somatoform disorder ( DSM-IV ) presence physical symptom suggest general medical condition fully explain general medical condition , direct effect substance , another mental disorder . The symptom must cause clinically significant distress impairment social , occupational , area function . The physical symptom voluntary control . Psychic factor exclusively combination medical disease factor influence onset , severity , exacerbation maintenance symptom decisively . A subgroup somatoform disorder , i.e. , fibromyalgia , common nonarticular rheumatic syndrome characterize myalgia multiple point focal muscle tenderness palpation ( trigger point ) . Muscle pain typically aggravated inactivity exposure cold . This condition often associate general symptom , sleep disturbance , fatigue , stiffness , headache , occasionally depression . There significant overlap fibromyalgia chronic fatigue syndrome . Fibromyalgia may arise primary secondary disease process . Interleukins IL-1ÃŸ , IL-6 und tumor necrosis factor-a detect skin patient . Blockade 5HT3 receptor report alleviate chronic pain tendopathy , fibromyalgia autoimmune disease . However , subgroup patient respond therapy . It suppose patient somatoform disorder ( DSM-IV ) diagnose accord clinical criterion consist immunologically heterogenous group . However , , immunologic genetic background patient somatoform disorder classify via DSM-IV systematically evaluate . The study concentrate psychometric characterization patient pain disorder focusing depression , anxiety , cop behavior , psychic trauma , alexithymia somatoform symptom . The present study perform define subgroup patient somatoform disorder ( DSM-IV ) immunological , pyschologic genetic characterization may benefit potential 5HT3 receptor antagonist anti-inflammatory therapy .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Fatigue Syndrome , Chronic</mesh_term>
	<mesh_term>Somatoform Disorders</mesh_term>
	<criteria>chronic pain patient somatoform disorder due DSMIV chronic pain &gt; 6 month several anatomical region presence physical symptom suggest general medical condition symptom must cause clinically significant distress impairment social , occupational , area function physical symptom voluntary control Psychic factor exclusively combination medical disease factor influence onset , severity , exacerbation maintenance symptom decisively fibromyalgia age &lt; 18 year psychosis symptom fully explain general medical condition , direct effect substance , another mental disorder pregnancy inclusion study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>human</keyword>
	<keyword>patient</keyword>
	<keyword>somatoform disorder</keyword>
	<keyword>fibromyalgia</keyword>
	<keyword>myofascial pain syndrome diffuse</keyword>
	<keyword>depression</keyword>
	<keyword>chronic fatigue syndrome</keyword>
	<keyword>inflammation</keyword>
	<keyword>inflammatory response</keyword>
	<keyword>biomarkers</keyword>
	<keyword>cytokine</keyword>
	<keyword>cell surface marker</keyword>
	<keyword>functional polymorphism</keyword>
</DOC>